Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
Upcoming event: RegSci Early Career Seminar with Annabelle Fowler
Come learn about regulatory science at FDA from Annabelle Fowler, current FDA Public Health and Regulatory Research Fellow and Harvard alum.
RegSci Forum: Benefit-Risk Analysis of Regulatory Decision-Making
May 11, 2021 12-1pm ET